Kiwa Bio-Tech Products Group Corporation

OTCPK:KWBT Stock Report

Market Cap: US$123.4k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Kiwa Bio-Tech Products Group Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Kiwa Bio-Tech Products Group's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Dec 2019

Recent past performance updates

No updates

Recent updates

No updates

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Kiwa Bio-Tech Products Group has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.

Show section

Revenue & Expenses Breakdown
Beta

How Kiwa Bio-Tech Products Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:KWBT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 1940-750
30 Sep 1940-140
30 Jun 1937-150
31 Mar 1931150
31 Dec 1831060
30 Sep 1839360
30 Jun 1831260
31 Mar 1826150
31 Dec 1717130
30 Sep 178-130
30 Jun 1710-120
31 Mar 1710020
31 Dec 1610110
30 Sep 161100
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150-100
30 Jun 150-100
31 Mar 150-100
31 Dec 140-100
30 Sep 140-100
30 Jun 140400
31 Mar 140400
31 Dec 130400
30 Sep 130300
30 Jun 130-100
31 Mar 130-100
31 Dec 120-100

Quality Earnings: Insufficient data to determine if KWBT has high quality earnings.

Growing Profit Margin: Insufficient data to determine if KWBT's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if KWBT's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare KWBT's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if KWBT's earnings growth over the past year exceeded the Biotechs industry average.


Return on Equity

High ROE: KWBT has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.